The global cost of cancer is projected to soar to $25.2 trillion by 2050, putting immense pressure on healthcare systems worldwide. ICPC is prepared to contribute to the imaginative reflection necessary to preserve healthcare innovation while easing the burden on low- and middle-income countries, which will bear a disproportionate share of the impact due to underdeveloped healthcare systems and limited fiscal capacity to finance care.
ICPC is determined to assist in exploring how local actions can inform global policy to mitigate the human and economic impact of cancer costs. It is committed to ensuring that treatment becomes accessible and affordable for patients everywhere. ICPC acknowledges that innovative actions by cities, tailored to the specific needs of local communities, can provide valuable insights for shaping comprehensive global policies to improve the future of cancer care.
To achieve these goals, ICPC will engage leaders from business, policy, academia, and civil society. It is ready to explore scaling up existing voluntary efforts to pool demand, support joint negotiations on effective and novel high-cost care, and collaborate to ensure better use of evidence for clinical and economic value.
Discover expert perspectives on the challenges and solutions for equitable cancer care and clinical trial access in the videos below:
- Dr. Piotr Rutkowski examines disparities in cancer treatment access across Europe, highlighting patient barriers and proposing strategies for promoting equitable care.
- Dr. Vivek Subbiah emphasizes the importance of expanding clinical trial access, particularly for rare cancers, addressing challenges in recruitment and the need for patient engagement in clinical research.
- Dr. Anna Czarnecka explores barriers to cancer care access, discussing policy’s role in ensuring equitable treatment and potential solutions to improve accessibility.
These discussions underscore the importance of global collaboration to overcome disparities in cancer care and research.
